Zevra Therapeutics, Inc. (ZVRA)
11.74
+0.18
(+1.51%)
USD |
NASDAQ |
Aug 31, 16:00
11.74
0.00 (0.00%)
After-Hours: 20:00
Zevra Therapeutics Cash from Operations (TTM) : 33.40M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.40M |
| March 31, 2026 | 12.77M |
| December 31, 2025 | -1.598M |
| September 30, 2025 | -23.36M |
| June 30, 2025 | -46.21M |
| March 31, 2025 | -61.72M |
| December 31, 2024 | -69.66M |
| September 30, 2024 | -69.57M |
| June 30, 2024 | -56.06M |
| March 31, 2024 | -45.66M |
| December 31, 2023 | -33.54M |
| September 30, 2023 | -21.84M |
| June 30, 2023 | -23.81M |
| March 31, 2023 | -19.28M |
| December 31, 2022 | -18.72M |
| September 30, 2022 | -15.10M |
| June 30, 2022 | -11.24M |
| March 31, 2022 | 9.54M |
| December 31, 2021 | 7.558M |
| September 30, 2021 | 7.347M |
| June 30, 2021 | 9.026M |
| March 31, 2021 | -5.384M |
| Date | Value |
|---|---|
| December 31, 2020 | -1.939M |
| September 30, 2020 | -3.978M |
| June 30, 2020 | -5.156M |
| March 31, 2020 | -14.69M |
| December 31, 2019 | -23.74M |
| September 30, 2019 | -35.82M |
| June 30, 2019 | -49.55M |
| March 31, 2019 | -51.35M |
| December 31, 2018 | -54.39M |
| September 30, 2018 | -46.14M |
| June 30, 2018 | -40.36M |
| March 31, 2018 | -37.68M |
| December 31, 2017 | -33.10M |
| September 30, 2017 | -35.81M |
| June 30, 2017 | -33.63M |
| March 31, 2017 | -35.43M |
| December 31, 2016 | -29.77M |
| September 30, 2016 | -26.53M |
| June 30, 2016 | -23.15M |
| March 31, 2016 | -20.13M |
| December 31, 2015 | -20.27M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Innoviva, Inc. | 191.49M |
| Collegium Pharmaceutical, Inc. | 329.92M |
| Johnson & Johnson | 27.61B |
| Ligand Pharmaceuticals, Inc. | 131.79M |
| Harrow, Inc. | 6.252M |